Glycopyrrolate Injection
Product Images NDC 68083-377

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 68083-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate-spl-1ml-carton-label (Glycopyrrolate Spl 1ml Carton Label)

This is the label of a medicine product called Glycopyrrolate Injection, USP. It comes in vials of 251 milliliters and is stored at temperatures between 20°C and 25°C. The medication is indicated to treat several conditions, but the dosage must be followed as specified on the package. The text seems to contain some errors and is unclear, but it might include information about the manufacturer and its representative.*

FDA Label Image

Glycopyrrolate-spl-1ml-container-label (Glycopyrrolate Spl 1ml Container Label)

This is a description of a medicine called Glycopyrrolate Injection, USP manufactured by Gland Ph: Limited. It comes in a 1mL single-dose vial with a strength of 0.2 mg/mL. The medicine also contains Benzyl alcohol. The text also includes information on manufacturing and expiry dates.*

FDA Label Image

Glycopyrrolate-spl-20ml-carton-label (Glycopyrrolate Spl 20ml Carton Label)

This appears to be a description of a medication. It is a multiple-dose vial containing water for injection and benzyl alcohol. The medication is not recommended for use on newborns and is designed for intramuscular or intravenous administration. The dosage is determined by the package insert and the medication should be stored in a USP Controlled Room Temperature. The manufacturer appears to be a company called Perry and it is located in India.*

FDA Label Image

Glycopyrrolate-spl-20ml-container-label (Glycopyrrolate Spl 20ml Container Label)

This is a description of a pharmaceutical product with NDC number 68083-379-01. The product is Water for Injection, USP and is only available through a prescription. It is manufactured by Gland Pharma Limited in Hyderabad, India and contains 0.9% Benzyl Alcohol (NF), which is used as a preservative. The pH can be adjusted with hydrochloric acid and/or sodium hydroxide as needed. The usual dosage instructions can be found in the package insert. The product is not intended for use in newborns and should be stored at room temperature between 20°C to 25°C. The product comes in a 20 mL multiple dose vial.*

FDA Label Image

Glycopyrrolate-spl-2ml-carton-label (Glycopyrrolate Spl 2ml Carton Label)

This is a description of an injectable medication called Glycopyrrolate Injection, USP. It comes in a package of 25 x 2mL single-dose vials. The medication is indicated for certain medical conditions, with the usual dosage provided in the package insert. The medication contains the active ingredient of glycopyrrolate and is manufactured in Hyderabad, India by G Prama Limited. It should be stored at room temperature.*

FDA Label Image

Glycopyrrolate-spl-2ml-container-label (Glycopyrrolate Spl 2ml Container Label)

This is a description of a medication with the NDC code 68083-377-01. It is named Glycopyrrolate ¢ 2 and is manufactured by Gland Pharma Limited in Hyderabad, India. The medication is in the form of an injection, with a concentration of 0.4 mg/2 mL (0.2 mg/mL). It is intended for IV or IM use and comes in a 2 mL single-dose vial. The medication contains benzyl alcohol and the lot number is 2IMDITS/2015/F/G with an expiry date of 12x10mm. It is only available by prescription.*

FDA Label Image

Glycopyrrolate-spl-5ml-carton-label (Glycopyrrolate Spl 5ml Carton Label)

FDA Label Image

Glycopyrrolate-spl-5ml-container-label (Glycopyrrolate Spl 5ml Container Label)

The text is describing a medication called Glycopyrrolate, which is available in a 0.2 mg/mL injection for IM or IV administration in a 5 mL multiple dose vial. The medication contains benzyl alcohol and is not recommended for use in newborns. The dosage should be determined as per the package instructions. It is produced by E Gland Pharma Limited, Hyderabad, India. The medication should be stored in an unvarnished area at a temperature between 20°C to 25°C (68°F to 77°F) as per USP Controlled Room Temperature guidelines.*

FDA Label Image

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.